Two Sigma Securities’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,040
Closed -$192K 2644
2022
Q3
$192K Buy
+2,040
New +$290K 0.01% 1979

Other funds holding CDLX

Two Sigma Securities's CDLX Position: Q1 2026 in Review

Two Sigma Securities reduced its Cardlytics (CDLX) stake by 13% in Q1 2026, selling an estimated $4.81K and leaving 3,162 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Two Sigma Securities first reported a position in CDLX in Q4 2019 and has held it in 4 quarters since. The position peaked at $205K in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Two Sigma Securities held 3,162 shares of Cardlytics worth $33.2K as of Q1 2026.
  • Two Sigma Securities sold 493 Cardlytics shares in Q1 2026, an estimated $4.81K.
  • Cardlytics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1311 holding.
  • Two Sigma Securities first reported a position in Cardlytics in Q4 2019 and has held it in 4 quarters since.
  • Two Sigma Securities's Cardlytics position peaked at $205K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.